About: Cirmtuzumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Cirmtuzumab (also UC-961) is an anti-ROR1 humanised monoclonal antibody. It is an experimental drug in early-stage clinical trials for various cancers including chronic lymphocytic leukemia (CLL).

Property Value
dbo:abstract
  • Cirmtuzumab (also UC-961) is an anti-ROR1 humanised monoclonal antibody. It is an experimental drug in early-stage clinical trials for various cancers including chronic lymphocytic leukemia (CLL). (en)
dbo:casNumber
  • 1643432-38-5
dbo:fdaUniiCode
  • FEH7RQ7B3J
dbo:wikiPageID
  • 58482991 (xsd:integer)
dbo:wikiPageLength
  • 3079 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1000125482 (xsd:integer)
dbo:wikiPageWikiLink
dbp:casNumber
  • 1643432 (xsd:integer)
dbp:legalStatus
  • Investigational (en)
dbp:source
  • zu (en)
dbp:synonyms
  • UC-961 (en)
dbp:target
dbp:type
  • mab (en)
dbp:unii
  • FEH7RQ7B3J (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Cirmtuzumab (also UC-961) is an anti-ROR1 humanised monoclonal antibody. It is an experimental drug in early-stage clinical trials for various cancers including chronic lymphocytic leukemia (CLL). (en)
rdfs:label
  • Cirmtuzumab (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License